TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Tuberculosis Vaccines Market Report & Forecast 2022-2028

Global and United States Tuberculosis Vaccines Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 13 October 2022
  • Pages :100
  • Formats:
  • Report Code:SMR-7438417
OfferClick for best price

Best Price: $3480

Tuberculosis Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Tuberculosis Vaccines Market

The global Tuberculosis Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tuberculosis Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tuberculosis Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tuberculosis Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tuberculosis Vaccines market.

Global Tuberculosis Vaccines Scope and Market Size

Tuberculosis Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Tuberculosis Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Segment by Application

  • Hospitals
  • Clinics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

By Company

  • Sanofi
  • Merck
  • Serum Institute of India
  • GlaxoSmithKline
  • Japan BCG Lab
  • IDT Biologics
  • GreenSignal Bio Pharma
  • Taj Pharmaceuticals
  • Bavarian Nordic
  • China National Biotec Group

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Tuberculosis Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Tuberculosis Vaccines, with price, sales, revenue, and global market share of Tuberculosis Vaccines from 2019 to 2022.

Chapter 3, the Tuberculosis Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Tuberculosis Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Tuberculosis Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccines.

Chapter 13, 14, and 15, to describe Tuberculosis Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Tuberculosis Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Tuberculosis Vaccines Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 100 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Tuberculosis Vaccines Product Introduction
1.2 Global Tuberculosis Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Tuberculosis Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Tuberculosis Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Tuberculosis Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Tuberculosis Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Tuberculosis Vaccines Sales in Volume for the Year 2017-2028
1.4 Tuberculosis Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Tuberculosis Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Tuberculosis Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Tuberculosis Vaccines Market Dynamics
1.5.1 Tuberculosis Vaccines Industry Trends
1.5.2 Tuberculosis Vaccines Market Drivers
1.5.3 Tuberculosis Vaccines Market Challenges
1.5.4 Tuberculosis Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Tuberculosis Vaccines Market Segment by Type
2.1.1 Immunotherapeutic Vaccines
2.1.2 Booster Vaccines
2.1.3 Others
2.2 Global Tuberculosis Vaccines Market Size by Type
2.2.1 Global Tuberculosis Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Tuberculosis Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Tuberculosis Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Tuberculosis Vaccines Market Size by Type
2.3.1 United States Tuberculosis Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Tuberculosis Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Tuberculosis Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Tuberculosis Vaccines Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Tuberculosis Vaccines Market Size by Application
3.2.1 Global Tuberculosis Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Tuberculosis Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Tuberculosis Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Tuberculosis Vaccines Market Size by Application
3.3.1 United States Tuberculosis Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Tuberculosis Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Tuberculosis Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Tuberculosis Vaccines Competitor Landscape by Company
4.1 Global Tuberculosis Vaccines Market Size by Company
4.1.1 Top Global Tuberculosis Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Tuberculosis Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Tuberculosis Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Tuberculosis Vaccines Price by Manufacturer (2017-2022)
4.2 Global Tuberculosis Vaccines Concentration Ratio (CR)
4.2.1 Tuberculosis Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Tuberculosis Vaccines in 2021
4.2.3 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Tuberculosis Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Tuberculosis Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Tuberculosis Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Tuberculosis Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Tuberculosis Vaccines Market Size by Company
4.5.1 Top Tuberculosis Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Tuberculosis Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Tuberculosis Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Tuberculosis Vaccines Market Size by Region
5.1 Global Tuberculosis Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Tuberculosis Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Tuberculosis Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Tuberculosis Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Tuberculosis Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Tuberculosis Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Tuberculosis Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Tuberculosis Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Tuberculosis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Tuberculosis Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Tuberculosis Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Tuberculosis Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Tuberculosis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Tuberculosis Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Tuberculosis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Tuberculosis Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Corporation Information
7.1.2 Sanofi Description and Business Overview
7.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Sanofi Tuberculosis Vaccines Products Offered
7.1.5 Sanofi Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Tuberculosis Vaccines Products Offered
7.2.5 Merck Recent Development
7.3 Serum Institute of India
7.3.1 Serum Institute of India Corporation Information
7.3.2 Serum Institute of India Description and Business Overview
7.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Serum Institute of India Tuberculosis Vaccines Products Offered
7.3.5 Serum Institute of India Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporation Information
7.4.2 GlaxoSmithKline Description and Business Overview
7.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 GlaxoSmithKline Tuberculosis Vaccines Products Offered
7.4.5 GlaxoSmithKline Recent Development
7.5 Japan BCG Lab
7.5.1 Japan BCG Lab Corporation Information
7.5.2 Japan BCG Lab Description and Business Overview
7.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Japan BCG Lab Tuberculosis Vaccines Products Offered
7.5.5 Japan BCG Lab Recent Development
7.6 IDT Biologics
7.6.1 IDT Biologics Corporation Information
7.6.2 IDT Biologics Description and Business Overview
7.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 IDT Biologics Tuberculosis Vaccines Products Offered
7.6.5 IDT Biologics Recent Development
7.7 GreenSignal Bio Pharma
7.7.1 GreenSignal Bio Pharma Corporation Information
7.7.2 GreenSignal Bio Pharma Description and Business Overview
7.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GreenSignal Bio Pharma Tuberculosis Vaccines Products Offered
7.7.5 GreenSignal Bio Pharma Recent Development
7.8 Taj Pharmaceuticals
7.8.1 Taj Pharmaceuticals Corporation Information
7.8.2 Taj Pharmaceuticals Description and Business Overview
7.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Products Offered
7.8.5 Taj Pharmaceuticals Recent Development
7.9 Bavarian Nordic
7.9.1 Bavarian Nordic Corporation Information
7.9.2 Bavarian Nordic Description and Business Overview
7.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Bavarian Nordic Tuberculosis Vaccines Products Offered
7.9.5 Bavarian Nordic Recent Development
7.10 China National Biotec Group
7.10.1 China National Biotec Group Corporation Information
7.10.2 China National Biotec Group Description and Business Overview
7.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 China National Biotec Group Tuberculosis Vaccines Products Offered
7.10.5 China National Biotec Group Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Tuberculosis Vaccines Industry Chain Analysis
8.2 Tuberculosis Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Tuberculosis Vaccines Distributors
8.3 Tuberculosis Vaccines Production Mode & Process
8.4 Tuberculosis Vaccines Sales and Marketing
8.4.1 Tuberculosis Vaccines Sales Channels
8.4.2 Tuberculosis Vaccines Distributors
8.5 Tuberculosis Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Tuberculosis Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Tuberculosis Vaccines Market Trends
Table 3. Tuberculosis Vaccines Market Drivers
Table 4. Tuberculosis Vaccines Market Challenges
Table 5. Tuberculosis Vaccines Market Restraints
Table 6. Global Tuberculosis Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Tuberculosis Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Tuberculosis Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Tuberculosis Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Tuberculosis Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Tuberculosis Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Tuberculosis Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Tuberculosis Vaccines Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Tuberculosis Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Tuberculosis Vaccines Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Tuberculosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Tuberculosis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Vaccines as of 2021)
Table 18. Top Players of Tuberculosis Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Tuberculosis Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Tuberculosis Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Tuberculosis Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Tuberculosis Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Tuberculosis Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Tuberculosis Vaccines Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Tuberculosis Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Tuberculosis Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Tuberculosis Vaccines Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Tuberculosis Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Tuberculosis Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Tuberculosis Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Tuberculosis Vaccines Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Tuberculosis Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Tuberculosis Vaccines Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Tuberculosis Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Sanofi Corporation Information
Table 43. Sanofi Description and Business Overview
Table 44. Sanofi Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Sanofi Tuberculosis Vaccines Product
Table 46. Sanofi Recent Development
Table 47. Merck Corporation Information
Table 48. Merck Description and Business Overview
Table 49. Merck Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Merck Product
Table 51. Merck Recent Development
Table 52. Serum Institute of India Corporation Information
Table 53. Serum Institute of India Description and Business Overview
Table 54. Serum Institute of India Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Serum Institute of India Product
Table 56. Serum Institute of India Recent Development
Table 57. GlaxoSmithKline Corporation Information
Table 58. GlaxoSmithKline Description and Business Overview
Table 59. GlaxoSmithKline Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. GlaxoSmithKline Product
Table 61. GlaxoSmithKline Recent Development
Table 62. Japan BCG Lab Corporation Information
Table 63. Japan BCG Lab Description and Business Overview
Table 64. Japan BCG Lab Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. Japan BCG Lab Product
Table 66. Japan BCG Lab Recent Development
Table 67. IDT Biologics Corporation Information
Table 68. IDT Biologics Description and Business Overview
Table 69. IDT Biologics Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. IDT Biologics Product
Table 71. IDT Biologics Recent Development
Table 72. GreenSignal Bio Pharma Corporation Information
Table 73. GreenSignal Bio Pharma Description and Business Overview
Table 74. GreenSignal Bio Pharma Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. GreenSignal Bio Pharma Product
Table 76. GreenSignal Bio Pharma Recent Development
Table 77. Taj Pharmaceuticals Corporation Information
Table 78. Taj Pharmaceuticals Description and Business Overview
Table 79. Taj Pharmaceuticals Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Taj Pharmaceuticals Product
Table 81. Taj Pharmaceuticals Recent Development
Table 82. Bavarian Nordic Corporation Information
Table 83. Bavarian Nordic Description and Business Overview
Table 84. Bavarian Nordic Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 85. Bavarian Nordic Product
Table 86. Bavarian Nordic Recent Development
Table 87. China National Biotec Group Corporation Information
Table 88. China National Biotec Group Description and Business Overview
Table 89. China National Biotec Group Tuberculosis Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 90. China National Biotec Group Product
Table 91. China National Biotec Group Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Tuberculosis Vaccines Customers List
Table 95. Tuberculosis Vaccines Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Tuberculosis Vaccines Product Picture
Figure 2. Global Tuberculosis Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Tuberculosis Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Tuberculosis Vaccines Sales 2017-2028 (K Doses)
Figure 5. United States Tuberculosis Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Tuberculosis Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Tuberculosis Vaccines Sales 2017-2028 (K Doses)
Figure 8. United States Tuberculosis Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Tuberculosis Vaccines Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Tuberculosis Vaccines Report Years Considered
Figure 11. Product Picture of Immunotherapeutic Vaccines
Figure 12. Product Picture of Booster Vaccines
Figure 13. Product Picture of Others
Figure 14. Global Tuberculosis Vaccines Market Share by Type in 2022 & 2028
Figure 15. Global Tuberculosis Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Tuberculosis Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Tuberculosis Vaccines Sales by Type (2017-2028) & (K Doses)
Figure 18. Global Tuberculosis Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Tuberculosis Vaccines Price by Type (2017-2028) & (USD/Dose)
Figure 20. United States Tuberculosis Vaccines Market Share by Type in 2022 & 2028
Figure 21. United States Tuberculosis Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Tuberculosis Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Tuberculosis Vaccines Sales by Type (2017-2028) & (K Doses)
Figure 24. United States Tuberculosis Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Tuberculosis Vaccines Price by Type (2017-2028) & (USD/Dose)
Figure 26. Product Picture of Hospitals
Figure 27. Product Picture of Clinics
Figure 28. Product Picture of Others
Figure 29. Global Tuberculosis Vaccines Market Share by Application in 2022 & 2028
Figure 30. Global Tuberculosis Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Tuberculosis Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Tuberculosis Vaccines Sales by Application (2017-2028) & (K Doses)
Figure 33. Global Tuberculosis Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Tuberculosis Vaccines Price by Application (2017-2028) & (USD/Dose)
Figure 35. United States Tuberculosis Vaccines Market Share by Application in 2022 & 2028
Figure 36. United States Tuberculosis Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Tuberculosis Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Tuberculosis Vaccines Sales by Application (2017-2028) & (K Doses)
Figure 39. United States Tuberculosis Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Tuberculosis Vaccines Price by Application (2017-2028) & (USD/Dose)
Figure 41. North America Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 42. North America Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 46. Europe Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 53. Asia-Pacific Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 65. Latin America Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Tuberculosis Vaccines Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 70. Middle East & Africa Tuberculosis Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Tuberculosis Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Tuberculosis Vaccines Value Chain
Figure 75. Tuberculosis Vaccines Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount